Trial
NCT04449380
Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Emanuele Bosi
Collaborators
—
Condition
COVID-19 Virus Infection
Intervention
Interferon-ß-1a
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-03